Albert S. Yu
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 6
- Biochemical and Molecular Research 5
- Genetics 17
- Chronic Lymphocytic Leukemia Research 16
- Co-authors
- Ian W. Flinn (12 shared papers)Steven Coutré (11 shared papers)Langdon L. Miller (5 shared papers)Brian J. Lannutti (8 shared papers)Leo M. Sreebny (2 shared papers)Anthony Valdini (2 shared papers)Nina D. Wagner‐Johnston (10 shared papers)Richard R. Furman (9 shared papers)
- Journals
- Blood (12 papers)Journal of Clinical Oncology (4 papers)The Journal of Urology (2 papers)International Journal of Impotence Research (2 papers)Scientific Reports (1 paper)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Albert S. Yu
47 papers receiving 3.2k citations
Albert S. Yu's Hit Papers
Peers
Comparison fields: 5 of 124
- Genetics 1.5k
- Pathology and Forensic Medicine 1.1k
- Sensory Systems 189
- Hematology 365
- Immunology 555
Countries citing papers authored by Albert S. Yu
This map shows the geographic impact of Albert S. Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert S. Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert S. Yu more than expected).
Fields of papers citing papers by Albert S. Yu
This network shows the impact of papers produced by Albert S. Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert S. Yu. The network helps show where Albert S. Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert S. Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia Hit paper breakdown → | 2014 | 470 |
| 2 | The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia Hit paper breakdown → | 2011 | 445 |
| 3 | 2014 | 201 | |
| 4 | 2015 | 192 | |
| 5 | 2014 | 167 | |
| 6 | 2005 | 145 | |
| 7 | 1989 | 132 | |
| 8 | 2014 | 132 | |
| 9 | 1992 | 131 | |
| 10 | 2010 | 100 | |
| 11 | 2008 | 96 | |
| 12 | 2003 | 95 | |
| 13 | 2010 | 91 | |
| 14 | 2016 | 86 | |
| 15 | 2006 | 84 | |
| 16 | 2022 | 72 | |
| 17 | 2011 | 60 | |
| 18 | 2001 | 58 | |
| 19 | 2019 | 54 | |
| 20 | 2000 | 51 |
About Albert S. Yu
Albert S. Yu is a scholar working on Molecular Biology, Genetics, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Sensory Systems, having authored 48 papers that have together received 3.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (16 papers), Ion Channels and Receptors (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Biochemical and Molecular Research (5 papers), Advanced Breast Cancer Therapies (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Genetics (1.5k citations), Pathology and Forensic Medicine (1.1k citations), Sensory Systems (189 citations), Hematology (365 citations) and Immunology (555 citations). Albert S. Yu has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Ian W. Flinn, Steven Coutré, Langdon L. Miller, Brian J. Lannutti, Leo M. Sreebny, Anthony Valdini, Nina D. Wagner‐Johnston, Richard R. Furman, Sissy Peterman and Brad S. Kahl. Their work appears in journals such as Blood, Journal of Clinical Oncology, The Journal of Urology, International Journal of Impotence Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.